Anti-Human IFNA1 Recombinant Antibody(Sifalimumab)

Name: Anti-Human IFNA1 Recombinant Antibody(Sifalimumab)
Brand: KMD Bioscience
SKU: YR1217

YR1217

科研级 Sifalimumab ( 西法木单抗 ), Anti-IFNA1 Recombinant Antibody, Research Grade Sifalimumab

DATASHEET MSDS

Product Description

Alias	科研级 Sifalimumab ( 西法木单抗 ), Anti-IFNA1 Recombinant Antibody, Research Grade Sifalimumab
Catalog Number	YR1217
Molecular Name	Sifalimumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a. Sifalimumab was developed by MedImmune, as of 2017 development had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials.
CAS Number	1006877-41-3
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	IFNA1[Homo sapiens]

Login